Celltrion lands W295b CMO deal with global pharma

Celltrion said Tuesday it has signed a 294.9 billion won ($198 million) contract manufacturing agreement with an undisclosed global pharmaceutical company to supply drug substance. The three-year deal runs from 2027 to 2029 and includes an option to expand to 375.4 billion won upon mutual agreement. The contract underscores Celltrion’s accelerating push into the global contract development and manufacturing organization market. Earlier this year, the company signed a 678.7 billion won CMO deal w

By The Korea Herald